Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals

AIDS

Volumn 30, Issue 14, 2016, Pages 2205-2214

  Fitch, Kathleen V ^a   DeFilippi, Christopher ^b   Christenson, Robert ^c   Srinivasa, Suman ^a   Lee, Hang ^d   Lo, Janet ^a   Lu, Michael T ^a   Wong, Kimberly ^a   Petrow, Eva ^a   Sanchez, Laura ^a   Looby, Sara E ^a   Hoffmann, Udo ^a   Zanni, Markella ^a   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d MGH Biostatistics Center   (United States)

Author keywords

Atherosclerotic plaque; Biomarkers; Cardiovascular diseases; HIV

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GALECTIN 3; OXIDIZED LOW DENSITY LIPOPROTEIN; TROPONIN T; BIOLOGICAL MARKER;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE CELL; MUSCLE INJURY; MYOFIBROSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VASCULITIS; ADOLESCENT; ANGIOGRAPHY; ASYMPTOMATIC DISEASE; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FIBROSIS; INJURY; MONOCYTE; PATHOLOGY; X-RAY TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOGRAPHY; ASYMPTOMATIC DISEASES; BIOMARKERS; CORONARY ARTERY DISEASE; FEMALE; FIBROSIS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MUSCLE CELLS; PLAQUE, ATHEROSCLEROTIC; TOMOGRAPHY, X-RAY; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84975126951     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001186     Document Type: Article

References (41)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2013). Global Report, UNAIDS report on the global AIDS epidemic 2013. http://www.unaids.org/sites/default/files/media- asset/UNAIDS-Global-Report-2013-en-1.pdf
2. Legarth RA, Ahlström MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr 2016; 71:213-218.
3. Siddiqi A-A, Hall HI, Hu X, Song R. Population-based estimates of life expectancy after HIV diagnosis. United States 2008-2011. J Acquir Immune Defic Syndr 2016; 72:230-236.
4. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet (London, England) 2013; 382:1525-1533.
5. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-1126.
6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-2512.
7. Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myo-cardial infarction. JAMA Intern Med 2013; 173:614-622.
8. Borges AH, O'Connor JL, Phillips AN, Rönsholt FF, Pett S, Vjecha MJ, et al. Determinants of IL-6 levels during HIV infection. J Int AIDS Soc 2014; 17 (4 Suppl 3):19482.
9. Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7: e44454.
10. R patients on virologically effective cART with early atherosclerosis. PLoS One 2012; 7:e46073.
11. McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, et al. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. J Infect Dis 2015; 211:1219-1228.
12. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204: 1227-1236.
13. Fitch KV, Srinivasa S, Abbara S, Burdo TH, Williams KC, Eneh P, et al. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. J Infect Dis 2013; 208:1737-1746.
14. Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010; 24:243-253.
15. Looby SE, Fitch KV, Srinivasa S, Lo J, Rafferty D, Martin A, et al. Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV. AIDS 2016; 30:383-393.
16. Zanni MV, Abbara S, Lo J, Wai B, Hark D, Marmarelis E, et al. Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men. AIDS 2013; 27:1263-1272.
17. Christenson RH, Duh S-H, Wu AHB, Smith A, Abel G, deFilippi CR, et al. Multicenter determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure. Clin Biochem 2010; 43:683-690.
18. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51 (4 Suppl): 5-40.
19. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-832.
20. Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol 2015; 12:588-596.
21. Gingo MR, Zhang Y, Ghebrehawariat KB, Jeong J-H, Chu Y, Yang Q, et al. Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort. PLoS One 2015; 10:e0123389.
22. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113:1958-1965.
23. Altintas S, Cardinaels EPM, Versteylen MO, Joosen IA, Seifert M, Wildberger JE, et al. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide. J Cardiovasc Comput Tomogr; 10:82-88.
24. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor H-U, Humpert PM, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angio-graphy characteristics of atherosclerotic plaque. Heart 2011; 97:823-831.
25. Seifarth H, Schlett CL, Lehman SJ, Bamberg F, Donnelly P, Januzzi JL, et al. Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography. J Cardiovasc Comput Tomogr; 8:452-458.
26. Januzzi JL, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010; 121:1227-1234.
27. Everett BM, Brooks MM, Vlachos HEA, Chaitman BR, Frye RL, Bhatt DL. Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med 2015; 373:610-620.
28. Ix JH, Katz R, Peralta CA, de Boer IH, Allison MA, Bluemke DA, et al. A high ankle brachial index is associated with greater left ventricular mass MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 55:342-349.
29. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010; 3:132-139.
30. Remick J, Georgiopoulou V, Marti C, Ofotokun I, Kalogeropou-los A, Lewis W, et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophy-siology, treatment, and future research. Circulation 2014; 129:1781-1789.
31. Daniels LB, Clopton P, Iqbal N, Tran K, Maisel AS. Association of ST2 levels with cardiac structure and function and mortality in outpatients. Am Heart J 2010; 160:721-728.
32. Secemsky EA, Scherzer R, Nitta E, Wu AHB, Lange DC, Deeks SG, et al. Novel biomarkers of cardiac stress, cardiovascular dysfunction, and outcomes in HIV-infected individuals. JACC Heart Fail 2015; 3:591-599.
33. Pascual-Figal DA, Januzzi JL. The biology of ST2: the International ST2 Consensus Panel. Am J Cardiol 2015; 115 (7 Suppl):3B-7B.
34. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie ANJ, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007; 117:1538-1549.
35. Fogel S, Guittaut M, Legrand A, Monsigny M, Hébert E. The tat protein of HIV-1 induces galectin-3 expression. Glycobiology 1999; 9:383-387.
36. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JPM, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 2004; 110:3121-3128.
37. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failureinthe community.J Am Coll Cardiol 2012; 60:1249-1256.
38. Thiara DK, Liu CY, Raman F, Mangat S, Purdy JB, Duarte HA, et al. Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults. J Infect Dis 2015; 212:1544-1551.
39. Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013; 128:814-822.
40. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47:742-748.
41. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304:2503-2512.